ARTICLE | Company News

TrovaGene, Sequenom deal terminated

August 11, 2011 12:11 AM UTC

TrovaGene Inc. (Pink:TROV) said a 2008 deal that gave Sequenom Inc. (NASDAQ:SQNM) rights to TrovaGene's transrenal technology has been terminated. TrovaGene (formerly Xenomics Inc.) did not disclose details. TrovaGene regains rights to patents covering transrenal fetal nucleic acids found in maternal urine for noninvasive prenatal and cancer diagnostics. TrovaGene added that it is in partnering discussions for the technology. Neither company could be reached for comment. ...